Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase.
This report contains market size and forecasts of Zanubrutinib in global, including the following market information:
Global Zanubrutinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Zanubrutinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Zanubrutinib companies in 2021 (%)
The global Zanubrutinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zanubrutinib include Cayman Chemical, BioVision, Selleck Chemicals, Biosynth Carbosynth, LifeSpan BioSciences, Clearsynth, Biorbyt, KareBay Biochem and MuseChem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zanubrutinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zanubrutinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Zanubrutinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Zanubrutinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Zanubrutinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Zanubrutinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Zanubrutinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zanubrutinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Zanubrutinib revenues share in global market, 2021 (%)
Key companies Zanubrutinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Zanubrutinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cayman Chemical
BioVision
Selleck Chemicals
Biosynth Carbosynth
LifeSpan BioSciences
Clearsynth
Biorbyt
KareBay Biochem
MuseChem
BOC Sciences
Beigene